Pharma Q3 Results Preview: Novartis, Lilly, Amgen, GSK

 
• By Sten Stovall, Mandy Jackson, and Lucie Ellis-Taitt

There's optimism around Novartis as it heads into its final quarter with Joe Jimenez in charge, while Lilly faces impending headwinds, GSK will be touting Shingrix for future growth as vaccines growth tempers, and Amgen treads a complicated path through the biosimilar landscape.

Stage curtains
Financial Results: The Curtain Raiser • Source: Shutterstock

More from Earnings

More from Business